Close Menu

NEW YORK – Rapid in vitro diagnostic maker Biolytical recently received prequalification status from the World Health Organization for its 60-second HIV self-test to detect antibodies to the virus directly from whole blood finger-stick samples. The firm has also begun a national collaboration to evaluate HIV self-testing in Canada that will ultimately support regulatory efforts there, and it is looking into the home-use regulatory pathway in the US as well.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.